Validation of an LC-MS/MS method for urinary homovanillic and vanillylmandelic ACIDS and application to the diagnosis of neuroblastoma
Background: Urinary catecholamine metabolites are well-established biomarkers for neuroblastoma (NB). Homovanillic acid (HVA) and vanillylmandelic acid (VMA) are the most frequently measured metabolites within SIOPEN – Catecholamine Working Group laboratories. Here, we evaluated the performance of a...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-04-01
|
| Series: | Journal of Mass Spectrometry and Advances in the Clinical Lab |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667145X25000148 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850039958546415616 |
|---|---|
| author | Lucilla Rossi Yvette A.H. Matser Sebastiano Barco Alessia Cafaro Federica Pigliasco Margherita Biondi Fabrizio Mancin Maria van der Ham Monique G.M. de Sain-van der Velden Shifra Ash Maja Beck Popovic André B.P. van Kuilenburg Massimo Conte Alberto Garaventa Godelieve A.M. Tytgat Giuliana Cangemi |
| author_facet | Lucilla Rossi Yvette A.H. Matser Sebastiano Barco Alessia Cafaro Federica Pigliasco Margherita Biondi Fabrizio Mancin Maria van der Ham Monique G.M. de Sain-van der Velden Shifra Ash Maja Beck Popovic André B.P. van Kuilenburg Massimo Conte Alberto Garaventa Godelieve A.M. Tytgat Giuliana Cangemi |
| author_sort | Lucilla Rossi |
| collection | DOAJ |
| description | Background: Urinary catecholamine metabolites are well-established biomarkers for neuroblastoma (NB). Homovanillic acid (HVA) and vanillylmandelic acid (VMA) are the most frequently measured metabolites within SIOPEN – Catecholamine Working Group laboratories. Here, we evaluated the performance of a new LC-MS/MS in vitro diagnostic (IVD) kit for HVA and VMA to facilitate inter-laboratory harmonization. Methods: HVA and VMA and their deuterated internal standards were analyzed with a commercial method, on a ThermoFisher Quantiva LC-MS/MS. Validation was performed first using internal quality control and external quality assessment (IQC and EQA) samples. Next by clinical validation on 120 samples, previously tested by HPLC-ECD. Finally, 36 samples were exchanged between SIOPEN reference laboratories and analyzed by three methods. Results: Using QCs and EQA the method was validated in a wide calibration range (4.61–830 µmol/L for HVA and 4.44–800 µmol/L for VMA). Intra-day CVs (n = 5) were 7 and 8 % for HVA and 5 and 6 % for VMA for QC low and QC high, respectively; Inter-day CV% were 7 and 3 % for HVA and 2 and 7 % for VMA at QC low and QC high, respectively. Its application to 120 clinical samples confirmed a high diagnostic accuracy. The inter-laboratory quality control assessment showed interchangeable results (p = 0,73 and p = 0.15 for HVA and VMA, respectively). Conclusion: The LC-MS/MS IVD method could be considered a useful tool for clinical laboratories involved in the measurement of catecholamines, contributing to harmonization efforts. |
| format | Article |
| id | doaj-art-0847aa65be924aee97ca59d2a2120c97 |
| institution | DOAJ |
| issn | 2667-145X |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Journal of Mass Spectrometry and Advances in the Clinical Lab |
| spelling | doaj-art-0847aa65be924aee97ca59d2a2120c972025-08-20T02:56:12ZengElsevierJournal of Mass Spectrometry and Advances in the Clinical Lab2667-145X2025-04-0136738110.1016/j.jmsacl.2025.04.007Validation of an LC-MS/MS method for urinary homovanillic and vanillylmandelic ACIDS and application to the diagnosis of neuroblastomaLucilla Rossi0Yvette A.H. Matser1Sebastiano Barco2Alessia Cafaro3Federica Pigliasco4Margherita Biondi5Fabrizio Mancin6Maria van der Ham7Monique G.M. de Sain-van der Velden8Shifra Ash9Maja Beck Popovic10André B.P. van Kuilenburg11Massimo Conte12Alberto Garaventa13Godelieve A.M. Tytgat14Giuliana Cangemi15Biochemistry, Pharmacology and Newborn Screening Unit, Central Laboratory of Analysis, IRCCS Istituto Giannina Gaslini, Genoa, Italy; Department of Chemical Sciences – DiSC, University of Padua, Padua, ItalyPrincess Máxima Center for Paediatric Oncology, Utrecht, The Netherlands; Laboratory of Genetic Metabolic Diseases, Amsterdam UMC University of Amsterdam, Amsterdam, The NetherlandsBiochemistry, Pharmacology and Newborn Screening Unit, Central Laboratory of Analysis, IRCCS Istituto Giannina Gaslini, Genoa, Italy; Corresponding author at: Chromatography and Mass Spectrometry Section, Central Laboratory of Analysis, IRCCS Istituto Giannina Gaslini, Via Gerolamo Gaslini 5, 16147 Genoa, Italy.Biochemistry, Pharmacology and Newborn Screening Unit, Central Laboratory of Analysis, IRCCS Istituto Giannina Gaslini, Genoa, ItalyBiochemistry, Pharmacology and Newborn Screening Unit, Central Laboratory of Analysis, IRCCS Istituto Giannina Gaslini, Genoa, ItalyBiochemistry, Pharmacology and Newborn Screening Unit, Central Laboratory of Analysis, IRCCS Istituto Giannina Gaslini, Genoa, ItalyDepartment of Chemical Sciences – DiSC, University of Padua, Padua, ItalyDepartment of Genetics, Section Metabolic Diagnostics, Wilhelmina Children’s Hospital, Utrecht, The NetherlandsDepartment of Genetics, Section Metabolic Diagnostics, Wilhelmina Children’s Hospital, Utrecht, The NetherlandsRuth Rappaport Children’s Hospital, Haifa, IsraelUniversity Hospital Lausanne, Lausanne, SwitzerlandLaboratory of Genetic Metabolic Diseases, Amsterdam UMC University of Amsterdam, Amsterdam, The Netherlands; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The NetherlandsPediatric Oncology and Hematology Department, IRCCS Istituto Giannina Gaslini, Genova, ItalyPediatric Oncology and Hematology Department, IRCCS Istituto Giannina Gaslini, Genova, ItalyPrincess Máxima Center for Paediatric Oncology, Utrecht, The NetherlandsBiochemistry, Pharmacology and Newborn Screening Unit, Central Laboratory of Analysis, IRCCS Istituto Giannina Gaslini, Genoa, ItalyBackground: Urinary catecholamine metabolites are well-established biomarkers for neuroblastoma (NB). Homovanillic acid (HVA) and vanillylmandelic acid (VMA) are the most frequently measured metabolites within SIOPEN – Catecholamine Working Group laboratories. Here, we evaluated the performance of a new LC-MS/MS in vitro diagnostic (IVD) kit for HVA and VMA to facilitate inter-laboratory harmonization. Methods: HVA and VMA and their deuterated internal standards were analyzed with a commercial method, on a ThermoFisher Quantiva LC-MS/MS. Validation was performed first using internal quality control and external quality assessment (IQC and EQA) samples. Next by clinical validation on 120 samples, previously tested by HPLC-ECD. Finally, 36 samples were exchanged between SIOPEN reference laboratories and analyzed by three methods. Results: Using QCs and EQA the method was validated in a wide calibration range (4.61–830 µmol/L for HVA and 4.44–800 µmol/L for VMA). Intra-day CVs (n = 5) were 7 and 8 % for HVA and 5 and 6 % for VMA for QC low and QC high, respectively; Inter-day CV% were 7 and 3 % for HVA and 2 and 7 % for VMA at QC low and QC high, respectively. Its application to 120 clinical samples confirmed a high diagnostic accuracy. The inter-laboratory quality control assessment showed interchangeable results (p = 0,73 and p = 0.15 for HVA and VMA, respectively). Conclusion: The LC-MS/MS IVD method could be considered a useful tool for clinical laboratories involved in the measurement of catecholamines, contributing to harmonization efforts.http://www.sciencedirect.com/science/article/pii/S2667145X25000148NeuroblastomaUrinary catecholamineLiquid Chromatography-tandem Mass SpectrometryPediatricsInter-laboratory harmonizationHomovanillic acid |
| spellingShingle | Lucilla Rossi Yvette A.H. Matser Sebastiano Barco Alessia Cafaro Federica Pigliasco Margherita Biondi Fabrizio Mancin Maria van der Ham Monique G.M. de Sain-van der Velden Shifra Ash Maja Beck Popovic André B.P. van Kuilenburg Massimo Conte Alberto Garaventa Godelieve A.M. Tytgat Giuliana Cangemi Validation of an LC-MS/MS method for urinary homovanillic and vanillylmandelic ACIDS and application to the diagnosis of neuroblastoma Journal of Mass Spectrometry and Advances in the Clinical Lab Neuroblastoma Urinary catecholamine Liquid Chromatography-tandem Mass Spectrometry Pediatrics Inter-laboratory harmonization Homovanillic acid |
| title | Validation of an LC-MS/MS method for urinary homovanillic and vanillylmandelic ACIDS and application to the diagnosis of neuroblastoma |
| title_full | Validation of an LC-MS/MS method for urinary homovanillic and vanillylmandelic ACIDS and application to the diagnosis of neuroblastoma |
| title_fullStr | Validation of an LC-MS/MS method for urinary homovanillic and vanillylmandelic ACIDS and application to the diagnosis of neuroblastoma |
| title_full_unstemmed | Validation of an LC-MS/MS method for urinary homovanillic and vanillylmandelic ACIDS and application to the diagnosis of neuroblastoma |
| title_short | Validation of an LC-MS/MS method for urinary homovanillic and vanillylmandelic ACIDS and application to the diagnosis of neuroblastoma |
| title_sort | validation of an lc ms ms method for urinary homovanillic and vanillylmandelic acids and application to the diagnosis of neuroblastoma |
| topic | Neuroblastoma Urinary catecholamine Liquid Chromatography-tandem Mass Spectrometry Pediatrics Inter-laboratory harmonization Homovanillic acid |
| url | http://www.sciencedirect.com/science/article/pii/S2667145X25000148 |
| work_keys_str_mv | AT lucillarossi validationofanlcmsmsmethodforurinaryhomovanillicandvanillylmandelicacidsandapplicationtothediagnosisofneuroblastoma AT yvetteahmatser validationofanlcmsmsmethodforurinaryhomovanillicandvanillylmandelicacidsandapplicationtothediagnosisofneuroblastoma AT sebastianobarco validationofanlcmsmsmethodforurinaryhomovanillicandvanillylmandelicacidsandapplicationtothediagnosisofneuroblastoma AT alessiacafaro validationofanlcmsmsmethodforurinaryhomovanillicandvanillylmandelicacidsandapplicationtothediagnosisofneuroblastoma AT federicapigliasco validationofanlcmsmsmethodforurinaryhomovanillicandvanillylmandelicacidsandapplicationtothediagnosisofneuroblastoma AT margheritabiondi validationofanlcmsmsmethodforurinaryhomovanillicandvanillylmandelicacidsandapplicationtothediagnosisofneuroblastoma AT fabriziomancin validationofanlcmsmsmethodforurinaryhomovanillicandvanillylmandelicacidsandapplicationtothediagnosisofneuroblastoma AT mariavanderham validationofanlcmsmsmethodforurinaryhomovanillicandvanillylmandelicacidsandapplicationtothediagnosisofneuroblastoma AT moniquegmdesainvandervelden validationofanlcmsmsmethodforurinaryhomovanillicandvanillylmandelicacidsandapplicationtothediagnosisofneuroblastoma AT shifraash validationofanlcmsmsmethodforurinaryhomovanillicandvanillylmandelicacidsandapplicationtothediagnosisofneuroblastoma AT majabeckpopovic validationofanlcmsmsmethodforurinaryhomovanillicandvanillylmandelicacidsandapplicationtothediagnosisofneuroblastoma AT andrebpvankuilenburg validationofanlcmsmsmethodforurinaryhomovanillicandvanillylmandelicacidsandapplicationtothediagnosisofneuroblastoma AT massimoconte validationofanlcmsmsmethodforurinaryhomovanillicandvanillylmandelicacidsandapplicationtothediagnosisofneuroblastoma AT albertogaraventa validationofanlcmsmsmethodforurinaryhomovanillicandvanillylmandelicacidsandapplicationtothediagnosisofneuroblastoma AT godelieveamtytgat validationofanlcmsmsmethodforurinaryhomovanillicandvanillylmandelicacidsandapplicationtothediagnosisofneuroblastoma AT giulianacangemi validationofanlcmsmsmethodforurinaryhomovanillicandvanillylmandelicacidsandapplicationtothediagnosisofneuroblastoma |